Lifevantage Current Ratio 2012-2026 | LFVN
Lifevantage current ratio from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Lifevantage Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-03-31 | $0.04B | $0.02B | 1.96 |
| 2025-12-31 | $0.04B | $0.02B | 2.03 |
| 2025-09-30 | $0.05B | $0.02B | 2.39 |
| 2025-06-30 | $0.05B | $0.03B | 1.87 |
| 2025-03-31 | $0.05B | $0.03B | 1.66 |
| 2024-12-31 | $0.05B | $0.03B | 1.66 |
| 2024-09-30 | $0.04B | $0.02B | 1.76 |
| 2024-06-30 | $0.04B | $0.02B | 1.69 |
| 2024-03-31 | $0.04B | $0.02B | 1.68 |
| 2023-12-31 | $0.04B | $0.02B | 1.68 |
| 2023-09-30 | $0.04B | $0.03B | 1.70 |
| 2023-06-30 | $0.04B | $0.02B | 2.26 |
| 2023-03-31 | $0.04B | $0.02B | 2.07 |
| 2022-12-31 | $0.04B | $0.02B | 1.90 |
| 2022-09-30 | $0.04B | $0.02B | 1.89 |
| 2022-06-30 | $0.05B | $0.03B | 1.83 |
| 2022-03-31 | $0.05B | $0.02B | 1.91 |
| 2021-12-31 | $0.04B | $0.02B | 1.93 |
| 2021-09-30 | $0.05B | $0.02B | 2.02 |
| 2021-06-30 | $0.05B | $0.03B | 1.91 |
| 2021-03-31 | $0.04B | $0.02B | 1.96 |
| 2020-12-31 | $0.04B | $0.02B | 1.89 |
| 2020-09-30 | $0.04B | $0.02B | 1.86 |
| 2020-06-30 | $0.04B | $0.03B | 1.75 |
| 2020-03-31 | $0.04B | $0.02B | 1.62 |
| 2019-12-31 | $0.04B | $0.03B | 1.49 |
| 2019-09-30 | $0.04B | $0.03B | 1.67 |
| 2019-06-30 | $0.04B | $0.03B | 1.65 |
| 2019-03-31 | $0.04B | $0.03B | 1.55 |
| 2018-12-31 | $0.04B | $0.03B | 1.52 |
| 2018-09-30 | $0.04B | $0.02B | 1.72 |
| 2018-06-30 | $0.04B | $0.02B | 1.64 |
| 2018-03-31 | $0.04B | $0.03B | 1.53 |
| 2017-12-31 | $0.04B | $0.02B | 1.55 |
| 2017-09-30 | $0.03B | $0.02B | 1.54 |
| 2017-06-30 | $0.04B | $0.02B | 1.52 |
| 2017-03-31 | $0.04B | $0.03B | 1.52 |
| 2016-12-31 | $0.04B | $0.02B | 1.56 |
| 2016-09-30 | $0.04B | $0.03B | 1.48 |
| 2016-06-30 | $0.04B | $0.03B | 1.41 |
| 2016-03-31 | $0.04B | $0.03B | 1.41 |
| 2015-12-31 | $0.04B | $0.04B | 1.05 |
| 2015-09-30 | $0.03B | $0.03B | 1.10 |
| 2015-06-30 | $0.03B | $0.03B | 1.18 |
| 2015-03-31 | $0.04B | $0.03B | 1.41 |
| 2014-12-31 | $0.04B | $0.02B | 1.79 |
| 2014-09-30 | $0.04B | $0.02B | 1.87 |
| 2014-06-30 | $0.04B | $0.02B | 1.76 |
| 2014-03-31 | $0.06B | $0.03B | 2.22 |
| 2013-12-31 | $0.05B | $0.02B | 2.41 |
| 2013-09-30 | $0.05B | $0.02B | 2.44 |
| 2013-06-30 | $0.05B | $0.02B | 2.23 |
| 2013-03-31 | $0.04B | $0.02B | 2.36 |
| 2012-12-31 | $0.04B | $0.02B | 2.37 |
| 2012-09-30 | $0.04B | $0.02B | 2.69 |
| 2012-06-30 | $0.04B | $0.02B | 2.42 |
| 2012-03-31 | $0.03B | $0.01B | 2.68 |
| 2011-12-31 | $0.02B | $0.02B | 1.36 |
| 2011-09-30 | $0.02B | $0.01B | 1.04 |
| 2011-06-30 | $0.01B | $0.01B | 0.77 |
| 2011-03-31 | $0.01B | $0.01B | 0.57 |
| 2010-12-31 | $0.01B | $0.01B | 0.85 |
| 2010-09-30 | $0.00B | $0.00B | 1.01 |
| 2010-06-30 | $0.00B | $0.01B | 0.59 |
| 2010-03-31 | $0.00B | $0.01B | 0.61 |
| 2009-12-31 | $0.00B | $0.01B | 0.33 |
| 2009-09-30 | $0.00B | $0.01B | 0.37 |
| 2009-06-30 | $0.00B | $0.00B | 0.80 |
| 2009-03-31 | $0.00B | $0.00B | 1.17 |
| 2008-12-31 | $0.00B | $0.00B | 1.72 |
| 2008-09-30 | $0.00B | $0.00B | 2.15 |
| 2008-06-30 | $0.00B | $0.00B | 1.71 |
| 2008-03-31 | $0.00B | $0.00B | 1.63 |
| 2007-12-31 | $0.00B | $0.00B | 1.94 |
| 2007-09-30 | $0.00B | $0.00B | 1.50 |
| 2007-06-30 | $0.00B | $0.00B | 0.96 |
| 2007-03-31 | $0.00B | $0.00B | 1.17 |
| 2006-12-31 | $0.00B | $0.00B | 1.31 |
| 2006-09-30 | $0.00B | $0.00B | 1.80 |
| 2006-06-30 | $0.00B | $0.00B | 2.04 |
| 2006-03-31 | $0.01B | $0.00B | 2.74 |
| 2005-12-31 | $0.01B | $0.00B | 3.53 |
| 2005-09-30 | $0.01B | $0.00B | 4.27 |
| 2005-06-30 | $0.01B | $0.00B | 7.01 |
| 2005-03-31 | $0.00B | $0.00B | 0.87 |
| 2004-12-31 | $0.00B | $0.00B | 0.06 |
| 2004-09-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.053B | $0.229B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |